BSEM
Price
$6.70
Change
-$0.02 (-0.30%)
Updated
Sep 5 closing price
Capitalization
112.06M
71 days until earnings call
CMVLF
Price
$2.60
Change
-$0.52 (-16.67%)
Updated
Sep 2 closing price
Capitalization
267.21M
Interact to see
Advertisement

BSEM vs CMVLF

Header iconBSEM vs CMVLF Comparison
Open Charts BSEM vs CMVLFBanner chart's image
BioStem Technologies
Price$6.70
Change-$0.02 (-0.30%)
Volume$27.93K
Capitalization112.06M
Cellectis Romainville
Price$2.60
Change-$0.52 (-16.67%)
Volume$160
Capitalization267.21M
BSEM vs CMVLF Comparison Chart in %
Loading...
BSEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMVLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSEM vs. CMVLF commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSEM is a Hold and CMVLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (BSEM: $6.70 vs. CMVLF: $2.60)
Brand notoriety: BSEM and CMVLF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BSEM: 40% vs. CMVLF: 72%
Market capitalization -- BSEM: $112.06M vs. CMVLF: $267.21M
BSEM [@Biotechnology] is valued at $112.06M. CMVLF’s [@Biotechnology] market capitalization is $267.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSEM’s FA Score shows that 0 FA rating(s) are green whileCMVLF’s FA Score has 1 green FA rating(s).

  • BSEM’s FA Score: 0 green, 5 red.
  • CMVLF’s FA Score: 1 green, 4 red.
According to our system of comparison, CMVLF is a better buy in the long-term than BSEM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSEM’s TA Score shows that 6 TA indicator(s) are bullish while CMVLF’s TA Score has 3 bullish TA indicator(s).

  • BSEM’s TA Score: 6 bullish, 2 bearish.
  • CMVLF’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, BSEM is a better buy in the short-term than CMVLF.

Price Growth

BSEM (@Biotechnology) experienced а -5.63% price change this week, while CMVLF (@Biotechnology) price change was -16.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.13%. For the same industry, the average monthly price growth was +10.99%, and the average quarterly price growth was +33.00%.

Reported Earning Dates

BSEM is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+2.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CMVLF($267M) has a higher market cap than BSEM($112M). CMVLF YTD gains are higher at: 73.333 vs. BSEM (-51.590). CMVLF has more cash in the bank: 196M vs. BSEM (110K). BSEM has less debt than CMVLF: BSEM (6.02M) vs CMVLF (94.8M).
BSEMCMVLFBSEM / CMVLF
Capitalization112M267M42%
EBITDAN/A-30.25M-
Gain YTD-51.59073.333-70%
P/E Ratio4.56N/A-
RevenueN/A56.3M-
Total Cash110K196M0%
Total Debt6.02M94.8M6%
FUNDAMENTALS RATINGS
BSEM vs CMVLF: Fundamental Ratings
BSEM
CMVLF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
29
Undervalued
PROFIT vs RISK RATING
1..100
76100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
9538
P/E GROWTH RATING
1..100
95100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CMVLF's Valuation (29) in the null industry is in the same range as BSEM (38). This means that CMVLF’s stock grew similarly to BSEM’s over the last 12 months.

BSEM's Profit vs Risk Rating (76) in the null industry is in the same range as CMVLF (100). This means that BSEM’s stock grew similarly to CMVLF’s over the last 12 months.

CMVLF's SMR Rating (98) in the null industry is in the same range as BSEM (100). This means that CMVLF’s stock grew similarly to BSEM’s over the last 12 months.

CMVLF's Price Growth Rating (38) in the null industry is somewhat better than the same rating for BSEM (95). This means that CMVLF’s stock grew somewhat faster than BSEM’s over the last 12 months.

BSEM's P/E Growth Rating (95) in the null industry is in the same range as CMVLF (100). This means that BSEM’s stock grew similarly to CMVLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSEMCMVLF
RSI
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 4 days ago
50%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
35%
Momentum
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
70%
MACD
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
48%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
67%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
60%
Advances
ODDS (%)
Bullish Trend 12 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
72%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
39%
View a ticker or compare two or three
Interact to see
Advertisement
BSEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMVLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFDSX25.220.35
+1.41%
DF Dent Small Cap Growth Investor
WIAEX40.630.11
+0.27%
Wasatch Small Cap Growth Institutional
FOSCX30.42N/A
N/A
Tributary Small Company Instl
RIVSX18.84-0.02
-0.11%
River Oak Discovery
FDFIX27.70-0.09
-0.32%
Fidelity Flex 500 Index

BSEM and

Correlation & Price change

A.I.dvisor tells us that BSEM and VICP have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BSEM and VICP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSEM
1D Price
Change %
BSEM100%
-0.22%
VICP - BSEM
23%
Poorly correlated
N/A
BMNDF - BSEM
11%
Poorly correlated
N/A
BVNRY - BSEM
9%
Poorly correlated
+0.57%
BIXT - BSEM
6%
Poorly correlated
+1.36%
CMVLF - BSEM
5%
Poorly correlated
N/A
More

CMVLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMVLF has been loosely correlated with TENX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CMVLF jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMVLF
1D Price
Change %
CMVLF100%
N/A
TENX - CMVLF
56%
Loosely correlated
-0.08%
SBHMY - CMVLF
51%
Loosely correlated
N/A
AURA - CMVLF
30%
Poorly correlated
+0.93%
ALDX - CMVLF
23%
Poorly correlated
+0.54%
TARS - CMVLF
23%
Poorly correlated
+0.35%
More